GREY:DGCRF - Post by User
Comment by
ready2go1on Jun 29, 2010 12:25pm
560 Views
Post# 17231020
RE: PCA3 in WSJ
RE: PCA3 in WSJthanks for the article. What hurts, is that there is no connection between Gen-Probe, PCA3 and Diagnocure. Investors become interested in what they hear, but put a few $'s in GPRO vs CUR. They are not going to spend alot of time researching what company is getting 8% of all sales, growing to 16% after $50 million.
I have had several patients in the past 2-3 yrs that donate millions to the local Hospital. I am talking 50-75 million, enough to get wings named after them. I spent some time talking to some of these individuals about investing in CUR and even went as far as them buying Diagnocure and donating PCA3 to the hospital, (a gift that keeps on giving yr after yr) and selling off GCC; raised alot of eyebrows, and I don't want to see this company aquired at a discount, but it has created a discussion.